Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francesca Parrotta has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Polynomial Model for Estimation of Ex-Vivo HIFU Thermal Lesion Dynamics Based on Pressure Amplitude and Sonication Time

    by Francesca Parrotta, Selene Tognarelli, Arianna Menciassi

    High-intensity focused ultrasound (HIFU) thermal therapy exploits concentrated acoustic energy to ablate pathological tissues with millimetric precision deep in the body. Accurate prediction of thermal effects is essential for tuning the treatment shooting parameters—such as source pressure amplitude and sonication time—as well as for maximizing efficacy and preserving surrounding healthy tissue. This study presents a computational model developed in COMSOL Multiphysics to simulate the physics of HIFU thermal phenomena, accounting for acoustic propagation and heat diffusion in biological tissues. The model was validated through experimental tests on ex vivo chicken breast tissue within a robotic ultrasound-guided HIFU (USgHIFU) platform, with lesion dimensions serving as the primary metric for validation. Building upon the validated simulation, we define a polynomial-based model that analytically predicts lesion dimensions based on the input shooting parameters. This approach significantly reduces the COMSOL computational cost and execution time, making it well-suited for integration into a real-time treatment planning workflow for clinical use. A desktop application implementing the inverse formulation of the polynomial model was developed, allowing shooting parameters to be computed from target lesion dimensions through a simple and intuitive interface. By enabling a rapid estimation of lesion size, this solution supports a more standardized strategy for non-invasive oncological therapies.

  • Open Access

    Membrane Sensorization for Acoustic Coupling Optimization in a Robotic HIFU Platform

    by Silvia Buratti, Daniele Moglia, Francesca Parrotta, Selene Tognarelli, Andrea Cafarelli, Mariangela Filosa, Calogero Maria Oddo, Arianna Menciassi

  • Open Access

    Improving Trans-Esophageal Echocardiography: A Miniaturized Cooling System

    by Francesca Parrotta, Giovanni Faoro, Selene Tognarelli, Alberto Giannoni, Arianna Menciassi

    Minimally Invasive Surgery (MIS) for cardiac procedures was adopted in the late 90s as a valid alternative to open-heart surgeries, allowing for a minor operative trauma and a faster post-operative recovery. In the context of MIS, the presence of accurate imaging techniques is of paramount importance, as surgeons operate without a direct view of the surgical site. Nowadays, fluoroscopic and ultrasound (US) images, using a Trans-Esophageal probe, are simultaneously employed. The development of real-time three-dimensional Trans-Esophageal Echocardiography has enabled the execution of various trans-catheter procedures. However, recent studies have highlighted the occurrence of esophageal lesions following TEE-guided cardiac interventions. Specifically, blind probe insertion and repeated adjustment for optimal instrument guidance, along with prolonged use-induced heating, appear to be the primary causes of complications. The major reason for using a dual imaging technique is that commercial probes automatically switch off once a temperature threshold of approximately 42.5∘C is reached; for safety reasons related to potential thermal damage to the internal walls of the esophagus. Based on numerical simulations and experimental results, a miniaturized cooling device for TEE probes is proposed, thus reinforcing the reliability of US images in the intraoperative scenario, as they are completely harmless to both patients and doctors. The proposed system consists of a silicone cap incorporating an internal cooling circuit. It does not interfere with the clinical workflow, effectively maintains the probe within a safe temperature range for the entire duration of a surgical procedure, and does not compromise intraoperative image quality.

  • Open Access

    High-Intensity Focused Ultrasound (HIFU) Modeling:In Vitro Validation and Integration into Patient-Specific Planning Tool

    by Fabio Morelli, Alessandro Albanesi, Alice Ivanaj, Silvia Buratti, Francesca Parrotta, Junling Fu, Selene Tognarelli, Arianna Menciassi, Elena De Momi, Alberto Redaelli

    This study aims at developing and experimentally validate a three-dimensional numerical model designed to predict acoustic propagation and thermal effects during High-Intensity Focused Ultrasound (HIFU) therapy, in order to support patient-specific treatment planning. A 3D time-domain simulation was implemented using the k-Wave toolbox, capturing both acoustic wave propagation and thermal effects. Validation was performed using five tissue-mimicking phantoms with distinct acoustic and thermal properties, each tested under three different HIFU exposure conditions. Lesion dimensions were assessed longitudinally and transversely in both simulations and experiments, and spatial concordance was quantified by evaluating the overlap between simulated and experimental lesions. Simulated longitudinal lesion extents fell within the interquartile range of experimental data in five out of nine phantom-condition combinations with a maximum absolute error of 2.70 mm while transverse dimensions in three out of nine with maximum absolute error equal to 4.16 mm. Spatial overlap between simulated and experimental lesions reached a maximum of 92%. Simulations on phantoms required approximately 16 minutes, while patient-specific cases completed in about 32 minutes, accurately capturing heterogeneous tissue characteristics and bone interfaces. In scenarios involving rib intersection, a 40% reduction in focal pressure was observed, leading to significant smaller lesions. The validated 3D simulation, integrated into a planning platform, reliably predicts HIFU ablation zones and focal shifts, showing strong agreement with experimental data and delivering results within clinically feasible times.